Metabolic manipulation of the tumour immune microenvironment
Authors:
Open Access
- 28 December 2021
- journal article
- review article
- Published by Wiley in Immunology
- Vol. 165 (3) , 290-300
Abstract
In the past few years, the evolution of immunotherapy has resulted in a shift in cancer treatment models. However, with immunosuppressive effects of the tumour microenvironment continues to limit advances in tumour immunotherapy. The tumour microenvironment induces metabolic reprogramming in cancer cells, which results in competition for nutrients between tumour cells and host immunocytes. Metabolic and waste products originating in tumour cells can influence the activation and effector properties of immunocytes in numerous ways and ultimately promote the survival and propagation of tumour cells. In this paper, we discuss metabolic reprogramming in tumour cells and the influence of metabolite by‐products on the immune microenvironment, providing novel insights into tumour immunotherapy.Keywords
Funding Information
- National Natural Science Foundation of China (32170910, 82072754)
- Natural Science Foundation of Jiangsu Province (BK20211124)
- Jiangsu Provincial Key Research and Development Program (BE2018689)
This publication has 104 references indexed in Scilit:
- Acidic extracellular microenvironment and cancerCancer Cell International, 2013
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T LymphocytesCancer Research, 2012
- Regulation of Macrophage Function by AdenosineArteriosclerosis, Thrombosis, and Vascular Biology, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- The Transcription Factor Myc Controls Metabolic Reprogramming upon T Lymphocyte ActivationImmunity, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cellsEuropean Journal of Immunology, 2008
- Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survivalJournal of Translational Medicine, 2007
- Indoleamine 2,3-dioxygenase and tumor-induced toleranceJournal of Clinical Investigation, 2007
- On the Origin of Cancer CellsScience, 1956